Find clinical trials for Lymphoma in Kansas City, KS
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Kansas City, KS, USA:
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Overland Park, Kansas, United States and 88 other locations
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Fairway, Kansas, United States and 125 other locations
TrAVeRse is a multicentre, open-label, randomised, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess...
Phase 2
Fairway, Kansas, United States and 47 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Kansas City, Kansas, United States and 66 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Fairway, Kansas, United States and 215 other locations
purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...
Phase 2
Kansas City, Missouri, United States and 82 other locations
in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton...
Phase 2
Kansas City, Missouri, United States and 85 other locations
This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...
Phase 3
Westwood, Kansas, United States and 119 other locations
This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.
Phase 2
Kansas City, Kansas, United States and 29 other locations
safety of ibrutinib given in combination with bendamustine and rituximab in patients 65 years of age or older with newly diagnosed mantle cell lymphoma...
Phase 3
Westwood, Kansas, United States and 203 other locations
Clinical trials
Research sites
Resources
Legal